Literature DB >> 9222685

Surgical treatment of cholangiocarcinoma.

F F Chou1, S M Sheen-Chen, Y S Chen, M C Chen, C L Chen.   

Abstract

BACKGROUND/AIMS: To report the results of surgical treatment of intrahepatic cholangiocarcinoma with different procedures and to find the factors that may affect the long-term survival.
MATERIALS AND METHODS: From 1987 to 1994, 57 patients with intrahepatic cholangiocarcinoma underwent laparotomy. Among them, resection was performed in 27 patients, operative drainage in 14 patients and biopsy only in 14 patients. The liver resections included 9 right lobectomies, 14 left lobectomies and 4 hilar resections. All specimens were stained with carcinoembryonic antigen (CEA) and HLA-DR monoclonal antibodies.
RESULTS: There were 7 postoperative mortalities, one in the resection group (1/27), two in the drainage group (2/14) and 4 in the biopsy group (4/14). Patients undergoing resection survived significantly longer (median, 8 months) (mean, 19 +/- 4 months) than patients undergoing drainage (median, 4 months) (mean, 6 +/- 2 months) and biopsy (median, 2 months) (mean, 3 +/- 1 months) (p < 0.01). After resection, univariate analysis showed that positive hiliar lymphnode was a poor prognostic sign and mucobilia was a good prognostic sign. Age, sex, size of tumors cell differentiation, clear margin, and positive HLA-DR and CEA had no effect on prognosis.
CONCLUSION: The results support the surgical resection of intrahepatic cholangiocarcinoma. Tumor free margin should be aggressively achieved but may not be necessary. Mucobilia is a good prognostic sign and positive hilar lymphnode is a grave sign.

Entities:  

Mesh:

Year:  1997        PMID: 9222685

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  19 in total

1.  Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma.

Authors:  Yuji Morine; Mitsuo Shimada; Tohru Utsunomiya; Satoru Imura; Tetsuya Ikemoto; Jun Hanaka; Mami Kanamoto; Nobuhiro Kurita; Hidenori Miyake
Journal:  Surg Today       Date:  2011-12-06       Impact factor: 2.549

2.  The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy?

Authors:  Sameer H Patel; David A Kooby; Charles A Staley; Juan M Sarmiento; Shishir K Maithel
Journal:  HPB (Oxford)       Date:  2011-07-26       Impact factor: 3.647

Review 3.  Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review.

Authors:  Linda Yang; Jocelyn Shan; Leonard Shan; Akshat Saxena; Lourens Bester; David L Morris
Journal:  J Gastrointest Oncol       Date:  2015-10

4.  Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin.

Authors:  G Pan; S M Vickers; A Pickens; J O Phillips; W Ying; J A Thompson; G P Siegal; J M McDonald
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 5.  Adjuvant therapy in biliary tract and gall bladder carcinomas: a review.

Authors:  Roshan S Prabhu; Jimmy Hwang
Journal:  J Gastrointest Oncol       Date:  2017-04

6.  [Surgical therapy of intrahepatic cholangiocellular carcinoma].

Authors:  H Lang; G C Sotiropoulos; E Brokalaki; N R Frühauf; J Radü; A Paul; J Wohlschlaeger; H A Baba; M Malagó; C E Broelsch
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

7.  Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma.

Authors:  Yuji Morine; Mitsuo Shimada; Tohru Utsunomiya; Satoru Imura; Tetsuya Ikemoto; Hiroki Mori; Jun Hanaoka; Mami Kanamoto; Hidenori Miyake
Journal:  Surg Today       Date:  2011-11-30       Impact factor: 2.549

8.  Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma.

Authors:  T Uenishi; K Hirohashi; S Kubo; T Yamamoto; H Hamba; H Tanaka; H Kinoshita
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

9.  Radiofrequency ablation for postoperative recurrences of intrahepatic cholangiocarcinoma.

Authors:  Ying Fu; Wei Yang; Wei Wu; Kun Yan; Bao-Cai Xing; Min-Hua Chen
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

10.  Diagnostic and surgical therapeutic features of extrahepatic bile duct carcinoma without jaundice.

Authors:  Hui-Huan Tang; Shi Chang; Xian-Wei Wang; Yun Huang; Xue-Jun Gong; Jun Zhou
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.